Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1586049

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1586049

Cancer Cachexia Market by Therapy (Combination Therapies, Corticosteroids, Progestogens), Functionality (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel - Global Forecast 2025-2030

PUBLISHED:
PAGES: 189 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Cancer Cachexia Market was valued at USD 2.09 billion in 2023, expected to reach USD 2.24 billion in 2024, and is projected to grow at a CAGR of 7.53%, to USD 3.48 billion by 2030.

Cancer cachexia is a complex syndrome characterized by severe weight loss, muscle wasting, and reduced food intake, frequently observed in cancer patients. The condition's definition extends beyond mere anorexia, encompassing metabolic changes that lead to significant morbidity and mortality risks. As a market research analyst, the necessity for understanding this syndrome lies in developing effective treatment options to improve the quality of life and survival rates of affected patients. Key applications include pharmaceuticals, nutritional supplements, and supportive care therapies, with end-use spanning hospitals, cancer treatment centers, and home care settings. Market growth is driven by increasing cancer prevalence, demanding more personalized and comprehensive therapeutic solutions. The growing focus on palliative care and patient-centric treatment further propels the market's expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 2.09 billion
Estimated Year [2024] USD 2.24 billion
Forecast Year [2030] USD 3.48 billion
CAGR (%) 7.53%

Factors impacting growth include advancements in biotechnology and ongoing research into metabolic pathways, providing opportunities for innovative drug development. The growing geriatric population, susceptible to cancer and, hence, cachexia, also boosts market potential. However, challenges such as complex drug development processes, high costs, and stringent regulatory requirements pose significant barriers. Furthermore, the heterogeneity of cancer cachexia, influenced by various cancer types and stages, complicates the standardization of treatment protocols.

Opportunities exist in exploring multi-modal treatment approaches, combining pharmacological and non-pharmacological interventions. Emerging research areas include understanding molecular mechanisms driving cachexia, which could lead to targeted therapies. Emphasis on personalized medicine and biomarkers offers potential for innovative products that cater to individual patient needs. Collaborations between pharmaceutical companies, research institutions, and healthcare providers can expedite these developments.

The market's nature is highly dynamic, driven by continual advancements in cancer research and therapeutic technologies. Companies focusing on developing integrated treatment regimes, improving patient nutrition, and enhancing overall patient management systems stand to gain a competitive edge. Identifying niche markets within geriatric oncology and enhancing patient education about cachexia management can further stimulate growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cancer Cachexia Market

The Cancer Cachexia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cachexia amongst the geriatric population
    • Presence of adequate reimbursement policies
    • Improving healthcare infrastructure and rise in awareness to treat cancer cachexia
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Technological advancements for the treatment of cancer cachexia
    • Rising number of research and development activities for the discovery of therapeutic drugs
  • Market Challenges
    • Implementation of stringent regulatory requirements and lengthy FDA approval

Porter's Five Forces: A Strategic Tool for Navigating the Cancer Cachexia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cancer Cachexia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cancer Cachexia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cancer Cachexia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cancer Cachexia Market

A detailed market share analysis in the Cancer Cachexia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cancer Cachexia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cancer Cachexia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cancer Cachexia Market

A strategic analysis of the Cancer Cachexia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Cachexia Market, highlighting leading vendors and their innovative profiles. These include AAVogen Inc., Actimed Therapeutics Ltd., Aeterna Zentaris Inc., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Fresenius Kabi AG, Green Cross Wellbeing Corporation, Helsinn Healthcare SA, INOVIO Pharmaceuticals Inc., Mankind Pharma Ltd., Merck & Co. Inc., MetaFines Co., Ltd., NeuBase Therapeutics, Inc., NGM Biopharmaceuticals Inc., Ono Pharmaceutical Co., Ltd., Pfizer Inc., and Tetra Bio-Pharma.

Market Segmentation & Coverage

This research report categorizes the Cancer Cachexia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapy, market is studied across Combination Therapies, Corticosteroids, and Progestogens.
  • Based on Functionality, market is studied across Appetite Stimulators and Weight Loss Stabilizers.
  • Based on Distribution Channel, market is studied across Hospital Stores, Online Pharmacy, and Retail Pharmacy Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-02026C4C92B4

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cachexia amongst the geriatric population
      • 5.1.1.2. Presence of adequate reimbursement policies
      • 5.1.1.3. Improving healthcare infrastructure and rise in awareness to treat cancer cachexia
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements for the treatment of cancer cachexia
      • 5.1.3.2. Rising number of research and development activities for the discovery of therapeutic drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Implementation of stringent regulatory requirements and lengthy FDA approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cancer Cachexia Market, by Therapy

  • 6.1. Introduction
  • 6.2. Combination Therapies
  • 6.3. Corticosteroids
  • 6.4. Progestogens

7. Cancer Cachexia Market, by Functionality

  • 7.1. Introduction
  • 7.2. Appetite Stimulators
  • 7.3. Weight Loss Stabilizers

8. Cancer Cachexia Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Stores
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy Stores

9. Americas Cancer Cachexia Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cancer Cachexia Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cancer Cachexia Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AAVogen Inc.
  • 2. Actimed Therapeutics Ltd.
  • 3. Aeterna Zentaris Inc.
  • 4. Aphios Corporation
  • 5. Artelo Biosciences Inc.
  • 6. AVEO Pharmaceuticals Inc.
  • 7. Boehringer Ingelheim International GmbH
  • 8. Bristol-Myers Squibb Company
  • 9. Fresenius Kabi AG
  • 10. Green Cross Wellbeing Corporation
  • 11. Helsinn Healthcare SA
  • 12. INOVIO Pharmaceuticals Inc.
  • 13. Mankind Pharma Ltd.
  • 14. Merck & Co. Inc.
  • 15. MetaFines Co., Ltd.
  • 16. NeuBase Therapeutics, Inc.
  • 17. NGM Biopharmaceuticals Inc.
  • 18. Ono Pharmaceutical Co., Ltd.
  • 19. Pfizer Inc.
  • 20. Tetra Bio-Pharma
Product Code: MRR-02026C4C92B4

LIST OF FIGURES

  • FIGURE 1. CANCER CACHEXIA MARKET RESEARCH PROCESS
  • FIGURE 2. CANCER CACHEXIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANCER CACHEXIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANCER CACHEXIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CANCER CACHEXIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CANCER CACHEXIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CANCER CACHEXIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CANCER CACHEXIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANCER CACHEXIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANCER CACHEXIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANCER CACHEXIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANCER CACHEXIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANCER CACHEXIA MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANCER CACHEXIA MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANCER CACHEXIA MARKET SIZE, BY PROGESTOGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANCER CACHEXIA MARKET SIZE, BY APPETITE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANCER CACHEXIA MARKET SIZE, BY WEIGHT LOSS STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANCER CACHEXIA MARKET SIZE, BY HOSPITAL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANCER CACHEXIA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANCER CACHEXIA MARKET SIZE, BY RETAIL PHARMACY STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CANCER CACHEXIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CANCER CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CANCER CACHEXIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CANCER CACHEXIA MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CANCER CACHEXIA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. CANCER CACHEXIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. CANCER CACHEXIA MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!